TINEACIDE - tolnaftate liquid 
Blaine Labs Inc.

----------

Active Ingredients

Drug facts

Active Ingredient

TOLNAFTATE 1%

Purpose

Purpose

Antifungal

Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison control Center right away.

Indications

Indications

Warnings

Warnings

When Using This Product

When using this product avoid contact with the eyes. If eye contact occurs, rinse thoroughly with water.

Stop Use And Consult A Physician

Stop use and ask a physician if irritation occurs or if there is no improvement within 4 weeks (for athlete's foot or ringworm) or within 2 weeks (for jock itch).

Directions

Directions

Other Information

Other Information

Questions?

Questions?

Call (800)307-8818, Monday through Friday, 8:00 AM to 5:00 PM (Pacific Time).

Inactive Ingredients

Inactive Ingredients

Paraffnum Liquidum, Carthamus Tinctorius (Safflower) Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Oreganum Vulgaris (Oregano) Leaf Oil, Tocopheryl acetate, BHT, BHA, Phenoxyethanol, Methylparaben, Ethylparaben, Propylparaben, Butylparaben, Isobutylpapaben.

Package Label Tineacide Solution Physician Formula

Blaine Labs

TINEACIDE SOLUTION PHYSICIAN FORMULA

Antifungal Treatment

Dispensed Only by Physicians

NDC: 63347-511-03

15ml (1/2 oz.)

Proudly Made in the USA

Please Recycle! This package is made from recyclable materials.

Exp. / Lot #

Patent Pending

Blaine Labs

Manufactured by

Blaine Labs, Inc

11037 Lockport Place

Sante Fe Springs, CA 90670

27000-P-BX Rev. 20120921

Blaine Tineacide Sol1

res

TINEACIDE  
tolnaftate liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63347-511
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE140 mg  in 15 mL
Inactive Ingredients
Ingredient NameStrength
MINERAL OIL (UNII: T5L8T28FGP)  
SAFFLOWER OIL (UNII: 65UEH262IS)  
JOJOBA OIL (UNII: 724GKU717M)  
OREGANO LEAF OIL (UNII: 7D0CGR40U1)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
ETHYLPARABEN (UNII: 14255EXE39)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
ISOBUTYLPARABEN (UNII: 0QQJ25X58G)  
BUTYLPARABEN (UNII: 3QPI1U3FV8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63347-511-0315 mL in 1 BOTTLE; Type 0: Not a Combination Product09/19/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00509/19/2012
Labeler - Blaine Labs Inc. (017314571)
Registrant - Blaine Labs Inc. (017314571)
Establishment
NameAddressID/FEIBusiness Operations
Blaine Labs Inc.017314571manufacture(63347-511)

Revised: 12/2023
Document Id: 7929e269-caee-4126-a9ba-14cbc2dd73d1
Set id: 273eb424-5dc3-40c8-9ea7-2f732cbd11c9
Version: 9
Effective Time: 20231221
 
Blaine Labs Inc.